179 related articles for article (PubMed ID: 34545713)
1. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
2. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
[TBL] [Abstract][Full Text] [Related]
4. eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy.
Fan Z; Cui X; Wei D; Liu W; Li B; He H; Ye H; Zhu N; Wei X
Sci Rep; 2016 May; 6():25353. PubMed ID: 27150264
[TBL] [Abstract][Full Text] [Related]
5. The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.
Hayashi M; Fukuhara H; Inoue K; Shuin T; Hagiya Y; Nakajima M; Tanaka T; Ogura S
PLoS One; 2015; 10(3):e0122351. PubMed ID: 25822972
[TBL] [Abstract][Full Text] [Related]
6. Regulating Photosensitizer Metabolism with DNAzyme-Loaded Nanoparticles for Amplified Mitochondria-Targeting Photodynamic Immunotherapy.
Zhao X; Cheng H; Wang Q; Nie W; Yang Y; Yang X; Zhang K; Shi J; Liu J
ACS Nano; 2023 Jul; 17(14):13746-13759. PubMed ID: 37438324
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the potential of Delta-aminolevulinic acid for simultaneous detection of bioburden and anti-microbial photodynamic therapy of MRSA infected wounds in Swiss albino mice.
Sahu K; Krishna H; Shrivastava R; Majumdar A; Chowdhury A; Chakraborty S; Majumder SK
J Photochem Photobiol B; 2024 May; 254():112892. PubMed ID: 38513542
[TBL] [Abstract][Full Text] [Related]
8. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA-PDT treatment of early oral cancer.
Khan S; Hussain MAB; Khan AP; Liu H; Siddiqui S; Mallidi S; Leon P; Daly L; Rudd G; Cuckov F; Hopper C; Bown SG; Akhtar K; Hasan SA; Siddiqui SA; Hasan T; Celli JP
J Biomed Opt; 2020 Apr; 25(6):1-10. PubMed ID: 32279466
[TBL] [Abstract][Full Text] [Related]
10. Prodrug-based strategy with a two-in-one liposome for Cerenkov-induced photodynamic therapy and chemotherapy.
Liu H; Wang Q; Guo J; Feng K; Ruan Y; Zhang Z; Ji X; Wang J; Zhang T; Sun X
J Control Release; 2023 Dec; 364():206-215. PubMed ID: 37884209
[TBL] [Abstract][Full Text] [Related]
11. Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma.
Belykh E; Miller EJ; Hu D; Martirosyan NL; Woolf EC; Scheck AC; Byvaltsev VA; Nakaji P; Nelson LY; Seibel EJ; Preul MC
World Neurosurg; 2018 May; 113():e51-e69. PubMed ID: 29408716
[TBL] [Abstract][Full Text] [Related]
12. Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma.
Jones PS; Yekula A; Lansbury E; Small JL; Ayinon C; Mordecai S; Hochberg FH; Tigges J; Delcuze B; Charest A; Ghiran I; Balaj L; Carter BS
EBioMedicine; 2019 Oct; 48():23-35. PubMed ID: 31628025
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles drug delivery for 5-aminolevulinic acid (5-ALA) in photodynamic therapy (PDT) for multiple cancer treatment: a critical review on biosynthesis, detection, and therapeutic applications.
Bhattacharya S; Prajapati BG; Singh S; Anjum MM
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17607-17634. PubMed ID: 37776358
[TBL] [Abstract][Full Text] [Related]
14. Comparison of minimal detectable protoporphyrin IX concentrations with a loupe device and conventional 5-ALA fluorescence microscopy: an experimental study.
Mischkulnig M; Traxler D; Wadiura LI; Lang A; Millesi M; Kiesel B; Widhalm G
J Biomed Opt; 2023 Oct; 28(10):106004. PubMed ID: 37915397
[TBL] [Abstract][Full Text] [Related]
15. Improved effectiveness of X-PDT against human triple-negative breast cancer cells through the use of liposomes co-loaded with protoporphyrin IX and perfluorooctyl bromide.
Yang B; Sang R; Li Y; Goldys EM; Deng W
J Mater Chem B; 2024 Apr; 12(15):3764-3773. PubMed ID: 38533806
[TBL] [Abstract][Full Text] [Related]
16. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
17. Correlation of in vitro cell viability and cumulative singlet oxygen luminescence from protoporphyrin IX in mitochondria and plasma membrane.
Li B; Shen Y; Lin H; Wilson BC
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104080. PubMed ID: 38583747
[TBL] [Abstract][Full Text] [Related]
18. 5-aminolevulinic acid sonodynamic therapy for cutaneous squamous cell carcinoma.
Li C; Yan J; Wang P; Zhang H; Zeng Q; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103801. PubMed ID: 37717674
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.
Maytin EV; Hasan T
Photochem Photobiol; 2020 May; 96(3):529-538. PubMed ID: 32077114
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
